News from Old College Capital

News Startup 7 Oct 2026

£2.5m investment in MiAlgae’s Grangemouth plant

Scottish biotech company MiAlgae has secured a £2.5m investment from the Scottish National Investment Bank to support the company’s new commercial-scale production facility in Grangemouth.

News Startup 24 Sep 2026

Student startup SolarSub raises £1.3m for solar panel technology

University of Edinburgh graduate startup SolarSub has raised £1.34 million for its cooling technology that helps solar panels run efficiently.

News Spinout 24 Aug 2026

Spinout Prothea presents first in-human study results

Cancer therapy company Prothea Technologies, a spinout of the University of Edinburgh, has presented clinical trial results demonstrating the potential for its imaging technology to provide molecular guidance during bronchoscopy.

News Spinout 19 Aug 2026

Singular Photonics raises $2m for SPAD-based image sensors

University of Edinburgh spinout Singular Photonics, a developer of SPAD-based image sensors, has raised $2.15 million to accelerate development of a new generation of sensors.

News Startup 20 Jul 2026

University companies bring new investors to Scotland, report shows

A fifth of new investment in Scotland last year went into University of Edinburgh companies, a recent report has shown.

News Spinout 25 Jun 2026

Spinout Pheno Therapeutics gets FDA clearance for MS clinical trials

University of Edinburgh biotechnology spinout Pheno Therapeutics has announced its lead therapeutic candidate has been cleared as an Investigational New Drug (IND) by the US Food and Drug Administration (FDA), allowing it to move to healthy volunteer studies.

News Startup 4 Jun 2026

Fintech startup Aveni announces £12m raise

University of Edinburgh startup Aveni, a leading AI specialist in wealth management, financial advice and banking, today announced £12 million raised in its latest funding round.

News Spinout 28 May 2026

Trogenix doses first patient in Phase I/II clinical trial of gene therapy for glioblastoma

University of Edinburgh spinout Trogenix has announced that the first patient has been dosed in a Phase I/II clinical trial to evaluate its novel gene therapy platform targeting brain cancer.

1 2 3 4 5 6 7 8 9

£2.5m investment in MiAlgae’s Grangemouth plant

Student startup SolarSub raises £1.3m for solar panel technology

Spinout Prothea presents first in-human study results

Singular Photonics raises $2m for SPAD-based image sensors

University companies bring new investors to Scotland, report shows

Spinout Pheno Therapeutics gets FDA clearance for MS clinical trials

Fintech startup Aveni announces £12m raise

Trogenix doses first patient in Phase I/II clinical trial of gene therapy for glioblastoma

What we do

Company

Find us

Useful links

Social links